Radiopharmaceuticals – Operational Implications in Strategic Program Design

Integrating radiopharmaceuticals and radioligand therapy (RLT) into clinical trials presents several operational challenges. As a result, several protocol decisions require significant forethought and careful planning. Despite the complexity, strategic decisions can greatly enhance treatment opportunities.